Organon NuvaRing contraceptive approved
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Organon's NuvaRing vaginal contraceptive ring, approved Oct. 3, is a non-biodegradable, flexible ring delivering a daily dose of 0.015 mg ethinyl estradiol and 0.120 mg etonogestrel. NuvaRing is inserted once a month and kept in place for three weeks. Under a pre-launch distribution program, Organon will offer the product free of charge for six months to 30,000 women. The company is expanding manufacturing facilities in the Netherlands and expects to have supplies for full product launch by May or June. The firm said that NuvaRing will be priced competitively to Pharmacia's monthly injection contraceptive Lunelle, which has an average wholesale price of $24.95 per monthly injection